Works matching IS 00333158 AND DT 2021 AND VI 238 AND IP 9
Results: 25
Comment on Flagel et al.: Sign-tracking as a predictor of addiction vulnerability.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Comment on Pohorala et al.: Sign-tracking as a predictor of addiction vulnerability.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Shared gray matter alterations in subtypes of addiction: a voxel-wise meta-analysis.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2365, doi. 10.1007/s00213-021-05920-w
- By:
- Publication type:
- Article
Sign tracking predicts suboptimal behavior in a rodent gambling task.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2645, doi. 10.1007/s00213-021-05887-8
- By:
- Publication type:
- Article
Evidence accumulation and associated error-related brain activity as computationally-informed prospective predictors of substance use in emerging adulthood.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2629, doi. 10.1007/s00213-021-05885-w
- By:
- Publication type:
- Article
NRG1 accelerates the forgetting of fear memories and facilitates the induction of long-term depression in adult mice.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2535, doi. 10.1007/s00213-021-05877-w
- By:
- Publication type:
- Article
Memory enhancing effects of nicotine, cocaine, and their conditioned stimuli; effects of beta-adrenergic and dopamine D2 receptor antagonists.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2617, doi. 10.1007/s00213-021-05884-x
- By:
- Publication type:
- Article
The GABA<sub>B</sub> receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2587, doi. 10.1007/s00213-021-05881-0
- By:
- Publication type:
- Article
Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2569, doi. 10.1007/s00213-021-05880-1
- By:
- Publication type:
- Article
Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2555, doi. 10.1007/s00213-021-05879-8
- By:
- Publication type:
- Article
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2543, doi. 10.1007/s00213-021-05878-9
- By:
- Publication type:
- Article
Adaptive aspects of impulsivity and interactions with effects of catecholaminergic agents in the 5-choice serial reaction time task: implications for ADHD.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2601, doi. 10.1007/s00213-021-05883-y
- By:
- Publication type:
- Article
No evidence of the clinical utility of single-item breakpoint to inform on tobacco demand in persons with substance use disorders.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2525, doi. 10.1007/s00213-021-05875-y
- By:
- Publication type:
- Article
Problem-solving deficits in methcathinone use disorder.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2515, doi. 10.1007/s00213-021-05874-z
- By:
- Publication type:
- Article
Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2503, doi. 10.1007/s00213-021-05872-1
- By:
- Publication type:
- Article
Resveratrol attenuates arsenic-induced cognitive deficits via modulation of Estrogen-NMDAR-BDNF signalling pathway in female mouse hippocampus.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2485, doi. 10.1007/s00213-021-05871-2
- By:
- Publication type:
- Article
Anticataleptic activity of nicotine in rats: involvement of the lateral entorhinal cortex.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2471, doi. 10.1007/s00213-021-05870-3
- By:
- Publication type:
- Article
Reduced cortical GABA and glutamate in high schizotypy.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2459, doi. 10.1007/s00213-021-05867-y
- By:
- Publication type:
- Article
Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2449, doi. 10.1007/s00213-021-05866-z
- By:
- Publication type:
- Article
Effects of the glucocorticoid receptor antagonist PT150 on stress-induced fentanyl seeking in male and female rats.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2439, doi. 10.1007/s00213-021-05865-0
- By:
- Publication type:
- Article
Acute intranasal dopamine application counteracts the reversal learning deficit of spontaneously hypertensive rats in an attentional set-shifting task.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2419, doi. 10.1007/s00213-021-05863-2
- By:
- Publication type:
- Article
Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2405, doi. 10.1007/s00213-021-05862-3
- By:
- Publication type:
- Article
The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2393, doi. 10.1007/s00213-021-05861-4
- By:
- Publication type:
- Article
Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2381, doi. 10.1007/s00213-021-05851-6
- By:
- Publication type:
- Article
Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 9, p. 2429, doi. 10.1007/s00213-021-05864-1
- By:
- Publication type:
- Article